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Abstract
Dimerization of G protein-coupled receptors (GPCRs) is crucial for receptor function including agonist affinity, efficacy, trafficking and specific-
ity of signal transduction, including G protein coupling. Emerging data suggest that the cardiovascular system is the main target of apelin, which
exerts an overall neuroprotective role, and is a positive regulator of angiotensin-converting enzyme 2 (ACE2) in heart failure. Moreover, ACE2
cleaves off C-terminal residues of vasoactive peptides including apelin-13, and neurotensin that activate the apelin receptor (APJ) and neuroten-
sin receptor 1 (NTSR1) respectively, that belong to the A class of GPCRs. Therefore, based on the similar mode of modification by ACE2 at pep-
tide level, the homology at amino acid level and the capability of forming dimers with other GPCRs, we have been suggested that APJ and
NTSR1 can form a functional heterodimer. Using co-immunoprecipitation, BRET and FRET, we provided conclusive evidence of heterodimeriza-
tion between APJ and NTSR1 in a constitutive and induced form. Upon agonist stimulation, hetrodimerization enhanced ERK1/2 activation and
increased proliferation via activation of Gq a-subunits. These novel data provide evidence for a physiological role of APJ/NTSR1 heterodimers
in terms of ERK1/2 activation and increased intracellular calcium and induced cell proliferation and provide potential new pharmaceutical targets
for cardiovascular disease.
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Introduction
Apelin is an adipokine that exerts pleiotropic effects on the cardio-
vascular system. Emerging data have suggested that apelin is a
positive regulator of angiotensin-converting enzyme 2 (ACE2) in
heart failure in vivo [1]. ACE2 is a negative regulator of the renin-
angiotensin system (RAS), since it catalyses the conversion of
angiotensin II (Ang II) to angiotensin 1-7 (Ang1-7) [2]. Ang1-7 has
been proposed to be one of key modulators of cardiovascular as
well as renal function, thus counterbalancing the effects of Ang II
and exerting a cardio-protective effect [3]. Moreover, apelin is a
substrate for catalytic ACE2 activity since it removes the C-terminal
phenylalanine of the peptide in vitro [4].
Apelin exerts its affects by binding and activating the apelin recep-
tor (APJ, gene symbol APLNR), a member of the GPCR super-family.
GPCRs are central to many of the body’s endocrine pathways and
represent a major therapeutic target class [5]. In terms of pharmacol-
ogy, APJ is capable of binding a number of apelin isoforms, activate
different classes of G protein a-subunits and subsequently induce
several signalling pathways in cell- and tissue-specific manner [2, 6].
In accordance with other ‘promiscuous’ GPCRs, APJ is also capable
of forming heterodimers with other GPCRs. For example, Chun et al.,
have shown using co-immunoprecipitation (Co-IP) and fluorescence
resonance energy transfer (FRET) analysis that the Ang II receptors
and APJ interacted physically [7]. Similarly, Co-IP, co-localization and
bioluminescence resonance energy transfer (BRET) assays confirmed
the heterodimerization of APJ and kappa opioid receptor (KOR) [8].
Interestingly, ACE2 also removed the C-terminal residue from the
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vasoactive peptide neurotensin in vitro [9]. Neurotensin binds and
activates the NTSR1 that is also a GPCR and shares 23% homology
with APJ. Moreover, NTSR1 is capable of forming heterodimers with
other GPCRs such as the dopamine D(2L) receptor [10] as well as
homodimers [11]. Given the similar mode of modification by ACE2 at
peptide level, as well as the homology at amino acid level and the
capability of forming dimers at receptor level, we have been
suggested that APJ and NTSR1 can form a functional heterodimer.
In this study, we provide conclusive evidence for heterodimeriza-
tion between NTSR1 and APJ using Co-IP, BRET and FRET in vitro. In
addition, treatment of HEK293-APJ/NTSR1 cells with respective agon-
ists significantly altered the phosphorylation status of ERK1/2 and
increased intracellular calcium and promoted cell proliferation com-
pared to cellular preparations where APJ or NTSR1 were expressed
individually. Our findings provide a novel insight into a higher order of
complexity on the signalling of apelin and neurotensin and provide a
novel functional role for a new GPCR heterodimer.
Materials and methods
Plasmid constructs
pRluc-NTSR1: the full length human NTSR1 gene was amplified by PCR
using the plasmid pcDNA3.1-NSTR1 (The Missouri S&T cDNA Resource
Center, Rolla, MO, USA) as template with forward primer: 50-ATAAGAAT
GCGGCCGCATGCGCCTCAACA GCTCCGCGCCG-30 (Not I site), and
reverse primer: 50-GTTTAAACGGGCCCT CTAGACTAGTAC-30 (Xba I site).
The PCR product was inserted into the cloning sites (Not I/Xba I) of
plasmid pRluc-N1 vector. The construction of pEGFP-APJ, pEYFP-APJ
and pECFP-NTSR1 followed an identical methodology, with using the
restriction enzyme sites EcoR I/BamH I for pEGFP-APJ or pEYFP-APJ
and Hind III/Kpn I for pECFP-NTSR1. Restriction enzymes were pur-
chased NEB (New England Biolabs, Hitchin, UK). All the constructs were
verified by direct DNA sequencing. APJ shRNA plasmids
(TRCN0000008097) and control shRNA plasmids (SHC002) were pur-
chased from Sigma-Aldrich (St. Louis, MO, USA).
Cell culture and transfection
Human umbilical vein endothelial cells (HUVEC; ATCC) were cultured in
RPMI-1640 medium supplemented with 10% (v/v) foetal bovine serum
(FBS; Life Technologies, Gaithersburg, MD, USA) at 37℃ with 5% CO2.
Human Embryonic Kidney 293 (HEK293; ATCC) were cultured in MEM
supplemented with 10% (v/v) FBS (Invitrogen Life Technologies). Tran-
sient transfection was performed with Lipofectamine 2000 (Life Tech-
nologies) according to the manufacturer’s protocol. Following
transfection, cells were maintained at 37°C with 5% CO2 for 6 hrs or
overnight before replacing media for further 12–24 hrs before use.
RNA extraction, cDNA synthesis and RT-PCR
Total RNA from HUVECs was extracted using the QIAGEN RNeasy kit (West
Sussex, UK), DNase treated, and reverse transcribed into cDNA using a
reverse transcriptase kit according to the manufacturer’s instructions (Fer-
mentas Life Sciences, York, UK). The sequences for the sense and antisense
primers respectively were: NTSR1: 50-CGCCAACAAGCTGACCGTCATG-30 and
50-GGCGATGACCA CTGCACGTAGG-30 (157 bp); APJ: 50-TCAGCAGCTACCT-
CATCTTC-30 and 50-AC TGCACCTTAGTGGTGTTC -30 (231 bp). HEK293 cDNA
was used as control for RT-PCR.
Enzyme-linked immunosorbent assay (ELISA)
A day prior to transfection, HEK-293 cells were plated at a density of
2 9 105 cells per well in 96-well plates. Transient transfection was per-
formed with HA-APJ, Myc-NTSR1 and cotransfected HA-APJ and Myc-
NTSR1 respectively, using Lipofectamine 2000 as previously described.
After 24 hrs, cells were fixed using 4% paraformaldehyde in PBS
(30 min. at 25°C). Fixed cells were washed three times with PBS, followed
by incubation with blocking buffer (3% skimmed milk powder for 1 hr at
25°C). Cells were then incubated with the primary rabbit anti-HA antibody
or anti-Myc antibody (1:500 in blocking buffer; Cell Signaling Technology,
MA, USA) overnight at 4°C, washed three times with PBS and incubated
with a peroxidase conjugated goat/rabbit secondary antibody (1:2000) in
DMEM for 1 hr at 37°C. The final substrate (200 ll) 3,30,5,50-tetramethyl-
benzidine (Sigma-Aldrich, St. Louis, MO, USA) was added and incubated for
30 min. at 37°C and the enzymatic reaction stopped with the addition of 50 ll
of 2 N H2SO4. The colorimetric reaction was measured using an iMark
TM Mi-
croplate reader (Bio-Rad, Hercules, CA, USA) at 450 nm wavelength.
Confocal laser scanning microscopy
HEK293 cells grown on coverslips were transiently transfection with
pEGFP-APJ and pcDNA3.1-NTSR1 and fixed after 24 hrs as previously
described. Non-specific binding was blocked by incubation with 3%
bovine serum albumin (BSA) in PBS-Triton X-100 (0.01%) for 1 hr at
room temperature. Cells were washed three times with PBS then incu-
bated overnight with anti-NTSR1 monoclonal antibody (1:200) in PBS at
4°C. Cells were washed three times with PBS followed by incubation for
1 hr at room temperature with Rhodamine-conjugated AffiniPure goat
anti-rabbit IgG (1:400). After final washes with PBS, cells were observed
using a laser scanning confocal microscope (oil-immersion x40 objec-
tive; TSC SP5, Leica, Germany).
Western blotting
Cells were washed with cold PBS and lysed in lysis buffer (50 mM
Tris–HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 10 mM MgCl2, 1 mM
DTT, 1 mM PMSF, 1 lg/ml leupeptin, 2 lg/ml aprotinin, 1.4 lg/ml pep-
statin A and 0.5% (v/v) NP-40). 10 lg of cell lysates were separated by
10% SDS-PAGE followed by transfer to PVDF membrane. Samples were
visualized as previously described [12]. The proteins of interest were
probed with primary antibodies described above.
Co-immunoprecipitation and western blotting
Co-immunoprecipitation was performed as previously described [7].
HEK293 cells were cotransfected with HA-APJ and Myc-NTSR1 or
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control vector. After 48 hrs, the cells were lysed in 800 ll lysis buffer
(120 mM NaCl, 0.5% NP-40, 100 mM NaF, 50 mM Tris–Cl, pH 8.0).
Following centrifugation at 4°C for 15 min. at 16,000 g, 500 ll of whole
cell lysates were incubated with 20 ll HA-conjugated Sepharose beads
(Cell Signaling Technology) for 4 hrs with gentle rotation at 4°C. The
beads were washed four times with cell lysis buffer. Protein complexes
were eluted with 2 9 SDS-PAGE sample buffer and anti-Myc and anti-
HA immunoreactivity was detected by western blotting. To monitor the
protein expression level, 10% of total cell lysates of each sample were
used for western blots.
BRET measurements
To monitor the constitutive interactions between NTSR1 and APJ, satu-
ration assays were performed: HEK293 cells were transfected with
pRluc-NTSR1 and pEGFP- APJ plasmids at a ratio of 1:0.5, 1:1, 1:1.5,
1:2, 1:2.5, 1:3 to express a constant amount of donor-labelled protein
with increasing amounts of acceptor-labelled protein to be assayed
[13]. About 24 hrs after transfection, cells were trypsinised and plated
on a 96-well microplate for 24 hrs in HEPES-buffered phenol red-free
medium (Invitrogen, Life Technologies). Cells were then washed and
re-suspended in 50 ll D-PBS. 5 lM of Coelenterazine h (Promega, South-
ampton, UK) was added for BRET measurements using the Tristar LB941
plate reader (Berthold Technologies, Bad Wildbad, Germany) with two filter
settings (Rluc filter, 400–475 nm; and EGFP filter, 500–550 nm). At the
same time, pRluc and pEGFP-APJ, pRluc-NTSR1 and pEGFP were detected
to eliminate the interference. BRET signal was detected and demonstrated
by mBRET (mBRET = BRET signal 9 1000).
To monitor the induced interaction between NTSR1 and APJ, BRET
signal was measured as described above with slight modification:
briefly, cells were transiently transfected with pRluc-NTSR1 and/or pEG-
FP-APJ and stimulated with Neurotensin (NT) (107 M) or apelin-13
(107 M) (Phoenix Pharmaceuticals, Belmont, USA) for 15 min. Follow-
ing washes, cells were re-suspended in D-PBS and 5 lM Coelenterazine
h was added for BRET measurements.
FRET imaging
FRET was also used to explore further the heterodimerization between
NTSR1 and APJ in living cells. The fluorescence of FRET channel (raw
FRET) comprises of the actual FRET and also the bleed-through from
the fluorescent proteins, namely, raw FRET = FRET+(A*recep-
tor)+(B*donor), so this FRET signal was corrected using Coefficient A
and Coefficient B, which describe bleed through correcting the raw
FRET image using the sensitized emission algorithm [14]. To obtain
these coefficients, cells were transfected with pEYFP and pECFP individ-
ually. After obtaining these coefficients, FRET was performed. Donor
plasmid pCFP-NTSR1 and receptor plasmid pEYFP-APJ were cotrans-
fected into HEK293 cells, in addition, pECFP-NTSR1 and pEYFP, pECFP
and pEYFP-APJ were also cotransfected into HEK293 cells as a negative
control. After 12–24 hrs, FRET signal was detected.
Knockdown of APJ in HUVEC
HUVECs were plated at 70–80% confluency before transfection. Cells
were transfected with APJ shRNA and control shRNA plasmids using
Lipofectamine 2000 according to the manufacturer’s instructions. About
12 hrs after transfection, the cells were screened by puromycin and
after 24 hrs, cells were washed twice with PBS, detached with trypsin
containing 0.25% EDTA and then distributed in a 6-well plate for
24 hrs. Then the cells were stimulated with NT or apelin-13 at 107 M
final concentration in serum free medium. Protein expression of interest
was assessed by Western blot analysis.
Calcium fluorescence measurement
Calcium signals were detected by using Fluo-4NM Calcium Assay Kits (In-
vitrogen, Carlsbad, California, USA) following manufacturer’s instructions.
HEK293-APJ, HEK293-NTSR1 and HEK293-APJ/NTSR1 were plated at
5 9 104 cells per well in a poly-d-lysine-coated black 96-well plate and
grown overnight. Fluo-4NW assay kit (Invitrogen) was then used. Briefly,
100 ll Fluo-4NW working solution was added to each well. Cells were
incubated at 37°C in 5% CO2 humidified chamber for 30 min., then at
room temperature for an additional 30 min. The plates were then washed
three times with an assay buffer to remove excess dye. Subsequently, all
cells were stimulated with apelin-13 or neurotensin and fluorescence were
immediately measured with the TriStar LB 941 Multimode Microplate
Reader (Berthold Technologies); DLR ready and appropriate for excitation
at 485 nm and emission at 525 nm. The calcium ratio was measured by
using the fluorescence value after adding the agonist taking away fluores-
cence value before adding agonist divided by the fluorescence value
before adding the agonist. The peak increase in fluorescence counts was
recorded for each well. All the experiments were repeated in triplicates.
NFAT luciferase reporter assays
For the nuclear factor of activated T-cells (NFAT) luciferase reporter
assay, cells stably expressing APJ, NTSR1 or APJ/NTSR1 were cotrans-
fected with the DNA of pNFAT-Luc (nuclear factor of activated T cells
tagged with luciferase) (PathDetect, Stratagene) which contain firefly
luciferase and pRL-Tk (Promega). About 24 hrs after transfection, the
cells were serum starved and stimulated with NT or apelin-13 at
107 M final concentration for 6 hrs prior to harvest. Relative lumines-
cence units (RLU) for firefly and renilla luciferase were determined
using Dual-Glo luciferase assay kits (Promega) according to the
manufacturer’s instructions.
Cell proliferation
HEK293 cells were transiently transfected with pcDNA3.1-NTSR1 and/or
pcDNA3.1-APJ and cultured in 96-well plates (1 9 104 cells per well) in
complete media treated with NT or apelin-13 at 107 M final concentra-
tion for 36 hrs. Cell proliferation was measured according to EnoGene
CellTM Counting Kit-8 (Promega) with iMarkTM Microplate reader (Bio-Rad).
Statistical analysis
Data are expressed as mean  SEM. Statistical comparisons were per-
formed with the Student’s t-test. In the case of multiple group compari-
sons, ANOVA was adopted. Differences among means were considered
significant when P < 0.05.
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Results
The endogenous expression of APJ and NTSR1 in
HUVECs
RT-PCR confirmed the expression of APJ and NTSR1 as 231 and
157 bp products respectively in HUVECs but not in HEK293 cells
(Fig. 1A and B). Both receptors are also expressed as proteins at
54 kD for APJ and a 43 kD for NTSR1 (Fig. 1C and D) in HUVECs.
Similarly, no apparent detection of either of the receptors was evident
in HEK293 cells.
NTSR1 and APJ are capable of co-expression
and co-localization
We examined whether of NTSR1 and APJ can be co-expressed. Cell
surface expression of HA-APJ and Myc-NTSR1 were measured by
ELISA using anti-HA and anti-Myc antibody in HEK293 cells express-
ing HA tagged APJ alone, Myc tagged NTSR1 alone or co-expressing
HA-APJ and Myc-NTSR1. Based on the absorbance readings co-
expression of NTSR1 and APJ does not alter their expression levels
(Fig. 2A). To study the co-localization of NTSR1 and APJ, immunoflu-
orescence analysis was carried out in HEK293 cells cotransfected
with plasmids expressing NTSR1 and APJ. Confocal laser scanning
microscopy revealed a high degree co-localization of NTSR1 and APJ,
predominantly around the plasma membrane, consistent with their
function as GPCRs as well as their potential capacity to form heterodi-
mers (Fig. 2B).
Assessment of NTSR1 and APJ
heterodimerization by co-immunoprecipitation,
BRET and FRET
Co-IP analysis of HA-APJ/Myc-NTSR1 in cotransfected HEK293,
revealed that only when both receptors were co-expressed, immuno-
reactive bands against the anti-HA and anti-Myc antibodies were
detected; indicative of a complex formation (Fig. 3). BRET studies
were carried out to study further the heterodimerization between
NTSR1 and APJ. In saturation assays, HEK293 cells cotransfected
with Rluc-NTSR1 and EGFP-APJ result in similar BRET signals to sat-
uration curves of positive control. However, the negative controls
result in BRET signals that increase with increasing concentrations of
acceptor-labelled protein in a quasi-linear manner (Fig. 4A), indicating
a constitutive interaction between NTSR1 and APJ.
Furthermore, treating co-expressed receptors with NT (107 M)
and/or apelin-13 (107 M), the BRET signals were significantly up-
regulated when compared to control unstimulated cells (Fig. 4B).
These data demonstrate an induced interaction between NTSR1 and
APJ upon agonist stimulation. When both agonists were used for
treatment, there was no additive effect.
FRET was carried out to provide further evidence for the heterodi-
merization between NTSR1 and APJ in living cells. The fluorescence
measurements resulted in the following parameters: Coefficient A and
Coefficient B is 0.39 and 0.55, respectively. No FRET signal was
detectable in pECFP-NTSR1 and pEYFP-APJ transfected alone.
However, a notable FRET signal detected only in pECFP-NTSR1 and
pEYFP-APJ cotransfected in HEK293 cells (Fig. 5), corroborating the
Co-IP and BRET findings.
NT and Apelin-13 induced ERK1/2 activation in
the HEK293-APJ/NTSR1 cells
Dose- and time-dependent effects of NT and Apelin-13 on ERK1/2 acti-
vation were then determined. Both ligands were able to induce phos-
phorylation of ERK1/2 upon treatment of HEK293 cells transfected
with their concomitant receptors or when the receptors were co-
expressed (Fig. 6A). Interestingly, ERK1/2 activation was significantly
higher in HEK293-APJ/NTSR1 group than that in HEK293-APJ group
treated with apelin-13 (108–105 M) or HEK293-NT group treated
with NT (108–105 M). ERK1/2 reached maximal phosphorylation
upon treatment with apelin-13 at 106 M or NT at 105 M (Fig. 6B).
With regard to time-dependent ERK1/2 activation, HEK293-AJP,
HEK293-NTSR1 and HEK293-APJ/NTSR1 cells were treated with
107 M NT or Apelin-13 for 0, 5, 15, 20 and 30 min. There was a sig-
nificant activation of ERK1/2 for apelin-13 treated HEK293-AJP and
HEK293-APJ/NTSR1 cells peaking at 5 min. after stimulation (Fig. 6C
and D). HEK293-NTSR1 and HEK293-APJ/NTSR1 cells treated with
NT demonstrated maximum phosphorylation of ERK1/2 at 10 min.
after treatment (Fig. 6C and D). In both cases, the degree of phos-
phorylation was greater when NTSR1 and APJ were co-expressed.
To eliminate the possibility that enhanced ERK activation was
caused by cross-agonism or other signalling effects, we tested the
A B
C D
Fig. 1 APJ and NTSR1 expression in HUVEC and HEK293 cells. RT-PCR
revealed that HUVECs but not HEK293 cells express APJ and NTSR1
(A, B). Similar expression was noted for both receptors at protein level
as they were detected by western blot (C, D). Lane M: DNA Ladder,
Lane 293: Untransfected HEK293 cells.
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effects of apelin-13 (107 M) on HEK293 cells expressing NTSR1 and
the effects of NT (107 M) treatment on HEK293 cells expressing
APJ. The results show that the increased ERK1/2 phosphorylation was
only observed in the cells expressing both receptors (Fig. 6E–G), and
there is no apparent interaction between apelin-13 with NTSR1, and
NT with APJ. Collectively, these indicate that there is no cross-agon-
ism between the two GPCRs and their cognate ligands.
RNAi to APJ compromised ERK1/2 activation in
HUVECs
HUVECs were transiently transfected with shRNA APJ and shRNA
Control as experimental group and control group respectively. Wes-
tern blot demonstrated that the protein expression in shRNA APJ
group was lower than that in shRNA group and basal group, while
there were no significant differences between shRNA Control group
and basal group (Fig. 7A), demonstrating that shRNA APJ can effec-
tively decrease the APJ expression at protein level. Then, shRNA APJ
group and shRNA group were stimulated with apelin-13 or NT, while
the basal group was constituted of unstimulated cells. When com-
pared to shRNA Control group, ERK1/2 activation in shRNA APJ group
was significantly decreased by apelin-13 stimulation. Interestingly,
decrease in APJ expression also resulted to a weaker ERK1/2 activa-
tion after NT stimulation (Fig. 7B and C). This effect could be because
of the heterodimerization of NTSR1 and APJ, involved in this particu-
lar signalling cascade.
Heterodimerization of APJ and NTSR1 enhances
NT or apelin-13 induced cell proliferation
Cell viability was measured from 0 to 36 hrs in treated cells with NT or
apelin-13 (107 M). Both NTSR1 and APJ stimulation significantly
induced cell proliferation (Fig. 8). Interestingly, the cell viability of
HEK293-APJ/NTSR1 group was also higher when compared to HEK293-
A
B
Fig. 2 Co-expression and co-localization of
APJ and NTSR1. Determination of cell
surface expression of HA-APJ and Myc-
NTSR1 by ELISA on intact cells using
anti-HA and anti-Myc antibody. Plasmids
expressing HA-tagged APJ or Myc-tagged
NTSR1 were transfected alone or in com-
bination, as illustrated. Values were pre-
sented as mean  SEM of triplicates (A).
pEGFP-APJ (green) and pcDNA3.1-NTSR1
were transfected into HEK293 for 24 hrs,
pcDNA3.1-NTSR1 was immunostained
with Rhodamine (red) and the cell nuclei
were stained with dye-DAPI (blue). Immu-
nofluorescence was measured with a
Leica fluorescent microscope (B).
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APJ or HEK293-NTSR1 group alone treated with apelin-13 or NT respec-
tively (Fig. 8A and B). These data demonstrate that activation of APJ/
NTSR1 heterodimers could increase HEK293 cell proliferation.
NTSR1 and APJ heterodimerization enhances the
Gq a-subunits activation
We dissected further the effects of dimerization on downstream signal
transcription by measuring nuclear factor of activated T-cells
response element (NFAT) using a double luciferase reporter assay.
Compared with control cells (basal), HEK293-AJP and HEK293-
NTSR1 cells, the activity of NFAT-luc was significantly increased in
HEK293-APJ/NTSR1 cells. HEK293 cells transfected only with AJP or
NTSR1, also demonstrated a moderate but significant induction of
NFAT luciferase activity compared to basal unstimulated levels
(Fig. 9). These results imply that heterodimerization of NTSR1 and
APJ significantly up-regulates NFAT activity, which involves the Gaq
pathway.
Heterodimerization of NTSR1 and APJ increase
intracellular Ca2+ upon agonist stimulation
As indicated, NTSR1 and APJ heterodimers can induce NFAT activity
via a Gaq pathway. To investigate this further, we evaluated changes
of calcium ions in cells after stimulation by apelin-13 and NT at
107 M. Treatment of HEK293-APJ/NTSR1 cells with apelin-13
resulted in significant up-regulation of fluorescence signal compared
with that of in HEK293-APJ cells. A similar effect was also noted
between HEK293-APJ/NTSR1 cells and HEK293-NTSR1 cells treated
with NT (Fig. 10A). This effect was observed on a wide range of ape-
lin-13 or NT concentrations: from 108 to 106 M (Fig. 10B and C).
These results provide conclusive evidence that heterodimerization
of NTSR1 and APJ could increase the level of calcium upon both ag-
onists stimulation. Since the Gaq activation leads to the increase in
intracellular calcium concentration, these results further strengthen
the hypothesis that the induction of NFAT activity relies on the activa-
tion of this G protein a-subunit.
Discussion
A plethora of studies have provided evidence for the interaction and
cross-talk of GPCRs, namely, the existence of homodimeric or hetero-
dimeric or even higher structure oligomers that are dependent, or
independent of agonist stimulation, which form new receptor com-
plexes and give receptors unique characteristics that exhibit func-
tional properties distinct from monomeric receptors involving agonist
recognition [15], G-protein preferences [16] and signalling. In partic-
ular, the apelin/APJ system plays a fundamental role in the
occurrence and development of cardiovascular diseases [2]. In this
study, we confirmed a high degree of co-localization of APJ with
NTSR1, predominantly on the plasma membrane of HEK293 cells. We
have also conclusively demonstrated that APJ and NTSR1 can exist
as heterodimers in constitutive and induced form by Co-IP, BRET and
FRET. Upon agonist stimulation, heterodimerization increased ERK1/2
activation, intracellular calcium and NFAT activity and induced cell
proliferation.
A
B
Fig. 4 HEK293 cells were transfected with a constant amount of pRluc-
NTSR1 with increasing amounts of pEGFP-APJ by 1:0.5, 1:1, 1:1.5, 1:2,
1:2.5, 1:3. BRET ratio demonstrated as mBRET (Mbret = BRET 9 1000).
All the results were expressed as mean  SEM of at least six independent
assays (A). HEK293 cells were transiently cotransfected with pRluc-
NTSR1 and pEGFP-APJ (1:1.5), and after 24 hrs upon addition of sub-
strate Coelenterazine-h, cells were treated with or without NT (107 M)
and/or apelin-13 (107 M) for 15 min. and BRET signals were analysed
(B). All the results were expressed as mean  SEM of at least six inde-
pendent assays. *P < 0.05 versus control; **P < 0.01 versus control.
Fig. 3 Assessment of dimerization between APJ and NTSR1 using co-
IP. HEK293 cells were mock transfected or transfected with expression
vectors of both HA-APJ and Myc-NTSR1 fusion proteins (cotransfected)
or with either vector alone. Confirmation of the expression of appropri-
ate constructs was obtained by immunoblotting cell lysates with either
anti- Myc or anti-HA antibodies (lower panel). The cell lysates were sub-
sequently immunoprecipitated (IP) with anti-HA antibody and immunob-
lotted with anti-Myc antibodies (upper panel) to demonstrate the
dimerization between APJ and NTSR1.
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In our in vitro system, ERK1/2 activation was significantly
enhanced in HEK293-APJ/NTSR1 cells compared to that in HEK293-
APJ or HEK293-NTSR1 cells after treatment with agonists. This effect
was also mirrored when cell proliferation and intracellular calcium
was measured. Recent studies have shown that apelin-13 increased
vascular smooth muscle cell proliferation by up-regulating the
expression of cyclin D1, which is involved in an ERK-dependent acti-
vation of Jagged-1/Notch3 signalling [2, 17]. In the same study, ape-
lin-13 was able to induce phosphorylation of ERK1/2 in a dose- and
time-dependent manner, thus corroborating our findings. Moreover,
the proliferative effect of apelin has been well documented in other
cells such as retinal endothelial cells [18], human osteoblasts and
gastric cells [19]. Interestingly, down-regulation of APJ expression
dampens not only apelin-13 but also NT induced ERK1/2 activation.
This finding was consistent with the increase in ERK1/2 phosphoryla-
tion in HEK293 cells co-expressing APJ and NTSR1. There was no
evidence of cross-agonism between the APJ and NTSR1 when
activated by NT and apelin-13 respectively.
Apelin/APJ and NT/NTSR1 system are co-expressed in a wide
range of tissues, playing a role in neuroprotection and involved in
neuropsychiatric and cardiovascular disease [20, 21]. APJ and
NTSR1 could exist as heterodimers in HUVECs therefore activation of
the dimeric GPCR complex might also mediate endothelial cell prolif-
eration and vascular functions such as angiogenesis. For example,
using HUVECs as a cellular model, Herr et al. have demonstrated the
potential capacity of angiotensin II in influencing angiogenesis by the
regulation of angiogenesis-associated genes via AGTR1[22]. How-
ever, the proliferative effects of this heterodimer have a scope beyond
vasculature, since injection of apelin into the ischaemic myocardium
facilitates neovascularization in the peri-infarct area [23].
We propose that activation of ERK1/2, followed by increased cell
proliferation in the heterodimeric state is primarily regulated by
activation of the Gq a-subunit and involves increase in intracellular
calcium. The receptors investigated in this study belong to GPCRs
A group and share very similar G-protein coupling preferences
(i.e. Gai/o and Gaq) to activate ERK1/2 [24, 25]. In a monomeric state,
NTSR1 can activate multiple G-proteins Gai, Gas and Gaq, but mainly
Gaq, whereas APJ can activate mainly Gai and partially Gaq. Upon
heterodimer formation between APJ and NTSR1, Gaq is preferentially
activated. This is in agreement with a previous study of the
Fig. 5 Assessment of dimerization between
APJ and NTSR1 using FRET assay.
HEK293 cells were cotransfected with
pCFP-NTSR1 and/or pYFP-APJ. Fluores-
cent images acquired using the indicated
filters 24 hrs after transfection. Pseudo-
color FRET images were generated by
MetaFluor 7.0 Software, with the lowest
FRET intensity in black and the highest
FRET intensity in red.
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Fig. 6 The effect of APJ and NTSR1 heterodimerization on ERK1/2 phosphorylation. Dose-dependent ERK1/2 phosphorylation HEK293-APJ or
HEK293-NTSR1 cells (upper panels) and HEK293-APJ/NTSR1 cells (lower panels) treated with Apelin-13 or NT (A). Summary of the dose–responses
of apelin-13 and NT on ERK1/2 activation (B). HEK293-APJ or HEK293-NTSR1 cells (Upper panels) and HEK293-APJ/NTSR1 cells (Lower panels)
were treated with apelin-13 or NT (107 M) from 5 to 30 min. (C). Quantification of all time-dependent treatments in HEK-293 cells expressing APJ,
NTSR1 or a combination of both (D). Effect of apelin-13 or NT (107 M) stimulation on ERK1/2 phosphorylation in HEK293, HEK293-APJ, HEK293-
NTSR1 or HEK293-APJ/NTSR1 cells (E, F). Quantification ERK1/2 phosphorylation corrected over total ERK of apelin-13 or NT treatments in HEK-
293 cells expressing APJ, NTSR1 or a combination of both (F). All the results were expressed as mean  SEM. *P < 0.05 versus Apelin-13 stimu-
lated HEK293-APJ groups; &P < 0.05 versus NT stimulated HEK293-NTSR1 group.
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cannabinoid (CB1) receptor and the dopamine D2 receptor (D2) hete-
rodimer. Co-expression of the D2 receptor was sufficient to switch
CB1 from Gai to Gas coupling, even in the absence of a D2 agonist
[26].
In an elegant study by White et al., it was shown that when NTSR1
exist as a monomer, it can activate readily Gaq, whereas upon receptor
homodimerization the catalysis of nucleotide exchange occurs less effi-
ciently [16]. The authors concluded that NTSR1 homodimerization is not
required for G protein activation. In our study, there is an augmentation
of signalling responses upon hetero- but not homodimerization. It is pos-
sible that the APJ/NTSR1 heterodimer does not really inhibit any of the G
protein a-subunits binding sites. Future studies using photoaffinity
A
B
C
Fig. 7 Effects of Knockdown APJ on ERK1/2 phosphorylation in HUVECs
APJ. shRNA efficiently knocks down APJ expression in HUVEC cells.
HUVECs were transfected with APJ shRNA or control shRNA. 48 hrs
after transfection, cell lysates were subjected to western blot and incu-
bated with antibodies against APJ. GAPDH was used as the loading
control (A). HUVECs were transfected as previous described and treated
with apelin-13 or NT at 107 M for 15 min. respectively. Cell lysates
were subjected to western blot and incubated with antibodies against
phosphor-ERK and total ERK. HUVECs without shRNA transfection and
agonist stimulation were used as basal control. Quantification of the
effects of APJ knockdown on ERK1/2 phosphorylation corrected over
total-ERK (C). All the results were expressed as mean  SEM.
*P < 0.05 versus basal group; **P < 0.01 versus basal group;
#P < 0.05 versus Control shRNA group.
A
B
Fig. 8 Effects of heterodimerization of APJ and NTSR1 on HEK293 cell
proliferation. HEK293-APJ cells and HEK293-APJ/NTSR1 cells were trea-
ted with apelin-13 (107 M) (A). HEK293-NTSR1 cells and HEK293-APJ/
NTSR1 cells were treated with NT (107 M) for 36 hrs (B). The cell prolif-
eration was measured by CCK assays. All the results were expressed as
mean  SEM.*P < 0.05 versus basal group, **P < 0.01 versus basal
group, $P < 0.05 versus Single (apelin-13 or NT) stimulated groups.
Fig. 9 The effect of dimerization between APJ and NTSR1 on Gaq acti-
vation. NFAT activities of HEK293-APJ, HEK293-NTSR1 and HEK293-
APJ/NTSR1 cells stimulated with apelin-13 (107 M) or NT (107 M).
All the results were expressed as mean  SEM. *P < 0.05 versus basal
group; **P < 0.01 versus basal group.
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labelling, or co-IP can provide a further insight into the binding capacity
of the heterodimer with various G proteins.
Collectively our data provide evidence for a novel signalling path-
way involving the formation of a new GPCR heterodimer. The implica-
tions of this finding can be of increasing significance for the regulation
of apelin/APJ system at cardiac level and beyond. For example, apelin-
deficient hearts in mice express significantly less ACE2 and in wild-
type mice activation of apelin-13/APJ system induced ACE2 expres-
sion in cardiomyocytes [1]. In another study, APJ/ embryos surviv-
ing to later stages demonstrated incomplete vascular maturation
because of a deficiency of vascular smooth muscle cells and impair-
ment of the ventricular wall development [27]. Recent studies demon-
strated that GPCR heterodimers have tremendous physiological
relevance, making them attractive drug targets in heath and disease
[28]. For instance, l-opioid receptor and a 2A-adrenergic receptor
can interact and affect the physiological processes such as neurogen-
esis [29]. In addition, angiotensin II type 1 receptor and bradykinin B2
receptor dimers play a critical role in preeclampsia because of
increase in angiotensin activity induced by the dimers [30]. Based on
our findings we believe APJ-NTSR1 dimers may be involved in RAS,
regulating cardiovascular physiology. For example, in cases of a defi-
ciency of apelin-13/APJ, heterodimerization with NTSR1, or treatment
with NT might exert a compensatory response and become an attrac-
tive therapeutic target. Future studies should concentrate on elucidat-
ing the heterodimerization of AJP/NTSR1 in cardiac tissues and
endothelial cells, and use them as experimental models to delineate
their precise role in cardiac physiology.
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Fig. 10 The effects of co-expression of APJ and NTSR1 on intracellular
Ca2 + . HEK293 cells expressing APJ, NTSR1 or APJ with NTSR1 cells
were plated in a poly-d-lysine coated 96-well plate, incubated overnight,
and assayed for a calcium response to apelin-13 or NT using the Fluo-4
DirectTM assay. Calcium fluorescence responses kinetics for apelin-13 or
NT stimulation was expressed in terms of fluorescent change over
background (A). Arrows mark the time of compound addition. (A) Each
fluorescent trace represents the calcium response resulting from a dose
of a single concentration (107 M) of apelin-13 or NT added to a single
well. The maxima of time periods (0–180 sec.) of each trace were used
dose–response curve construction for apelin-13 (B) or NT (C)
responses, respectively. Data represented as mean  SEM of three
measurements from three independent experiments. *P < 0.05,
***P < 0.01, ***P < 0.001 compared to single transfected groups.
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